Back to Results
First PageMeta Content
Purines / Medicine / Bristol-Myers Squibb / Fixed dose combination / Organofluorides / Rega Institute for Medical Research / Tenofovir / Emtricitabine/tenofovir/efavirenz / Emtricitabine / Gilead Sciences / Chemistry / Organic chemistry


Erik De Clercq, M.D. Ph.D. A pioneer in antiviral research, Dr. Erik De Clercq began his medical career in 1966, received his certification in Clinical Pathology in 1971, and his Ph.D. the
Add to Reading List

Document Date: 2012-05-11 13:47:20

Open Document

File Size: 247,47 KB

Share Result on Facebook

Company

Journal Antiviral Research Dr. De Clercq / /

Country

Belgium / /

EntertainmentAwardEvent

the Hamao Umezawa Memorial Award / the René Descartes Prize / The Otto Krayer Award / the Lifetime Achievement Award / /

Facility

Rega Institute / Leuven University / /

IndustryTerm

pharmaceutical / therapy for HIV / /

MedicalCondition

HIV / human papilloma / herpes / hepatitis C / hepatitis B / viral infections / HIV/AIDS / /

MedicalTreatment

chemotherapy / antiviral therapy / /

Organization

Rega Institute for Medical Research / Rega Foundation / National Science Foundation / International Society / American Association for the Advancement of Science / European Academy of Sciences / European Union / Rega Institute / Royal Academy of Medicine / Leuven University / /

Person

Erik De Clercq / Paul Janssen / /

Position

Editor-in-Chief / Chairman of the Department / Board Member / director positions / Chairman / President / Director / scientific advisor / /

Product

efavirenz / Tenofovir disoproxil fumarate / Valtrex / Vistide / Truvada / Hepsera / Viread / Atripla / /

ProgrammingLanguage

Pascal / /

PublishedMedium

Antiviral Research / /

Technology

chemotherapy / /

URL

www.pauljanssenaward.com / /

SocialTag